Tech Transfer eNews Blog
University-Industry Engagement Advisor

Deerfield and Harvard launch $100M venture to take new healthcare technologies to market


By Jesse Schwartz
Published: March 20th, 2019

Harvard University and healthcare investment firm Deerfield Management have struck a major agreement to launch a new company focused on biomedical and life science innovations.

Backed by a $100 million investment from Deerfield, Lab1636 is intended to transform early-stage research from Harvard into effective, real-world treatments for a range of medical conditions. Deerfield will provide support by guiding university technologies through the various stages of drug discovery and development. It’s the latest in a string of companies launched by Deerfield with big research universities that are designed to take new healthcare technologies further along the development path than TTOs are typically capable of doing on their own.

“Success in a research alliance requires a partner with a long vision and operational and development expertise, as well as the financial resources,” says Isaac T. Kohlberg, senior associate provost and chief technology development officer at Harvard. “We’re delighted to launch this initiative with Deerfield.”

In addition to supporting the development of research on campus, Lab1636 may assist in the process of licensing Harvard technologies out to existing companies and is equipped to help launch and grow new start-ups based on university research.

“The sheer scope of this collaboration with Deerfield may prove transformative for Harvard research,” says Vivian Berlin, managing director of strategic partnerships in the university’s Office of Technology Development. “This alliance has immense potential to bridge the development gap, ensure continuity of resources and complement our other major translational programs.”

James E. Flynn, managing partner at Deerfield, comments, “Harvard is an outstanding partner for an alliance. The university’s outstanding science, breadth of technologies and mix of esteemed junior and senior faculty constitute a fertile environment for the continuous generation of novel insights. This, in combination with its experience advancing potential therapeutics, makes it the perfect place to establish an impactful translational partnership.”

Source: AP News

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment